Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes
| Status: | This study is currently recruiting participants |
| First Received: | August 5, 2011 |
| Information provided by: | Shandong University |
| Sponsors and Collaborators: | Shandong University |
| Contacts: | chengyun zheng, Ph. D +86-531-85875635 chengyun.zheng@ki.se kdx2002@126.com |
Stem Cells Infusion With Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus
| Status: | This study is ongoing, but not recruiting participants. |
| First Received: | October 6, 2008 |
| Information provided by: | Fuzhou General Hospital |
| Sponsors and Collaborators: | Fuzhou General Hospital |
| Contacts: | none |
Effect of Thiazolidinediones on Human Bone
| Status: | Recruiting |
| First Received: | June 24, 2009 |
| Information provided by: | Emory University |
| Sponsors and Collaborators: | Emory University |
| Contacts: | Natasha B khazai, M.D. ☎ 404-778-1678 ➔ nkhazai@emory.edu Guillermo umpierrez, M.D. ☎ 404-778-1665 ➔ geumpie@emory.edu |
Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients
| Status: | Recruiting |
| First Received: | December 7, 2010 |
| Information provided by: | University of Sao Paulo |
| Sponsors and Collaborators: | University of Sao Paulo |
| Contacts: | Julio Voltarelli, MD, PhD ☎+55 16 2101 9369 ➔ jcvoltar@fmrp.usp.br Carlos E Couri ☎+5516 91495151 ➔ ce.couri@yahoo.com.br |
Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus
| Status: | Active, not recruiting |
| First Received: | October 12, 2010 |
| Information provided by: | Qingdao University |
| Sponsors and Collaborators: | Qingdao University |
| Contacts: | / |
Treatment of Patients With Newly Onset of Type 1 Diabetes With Mesenchymal Stem Cells
| Status: | Not yet recruiting |
| First Received: | February 16, 2010 |
| Information provided by: | Uppsala University Hospital |
| Sponsors and Collaborators: | Uppsala University Hospital |
| Contacts: | Per-Ola Carlsson, MD, PhD ☎ +46 18 471 4425 ➔ Per-Ola.Carlsson@mcb.uu.se Olle Korsgren, MD, PhD ☎ +46 18 6114187 ➔ Olle.Korsgren@klinimm.uu.se |
Autologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes
| Status: | Not yet recruiting |
| First Received: | February 16, 2010 |
| Information provided by: | Uppsala University Hospital |
| Sponsors and Collaborators: | Uppsala University Hospital |
| Contacts: | Per-Ola Carlsson, MD, PhD ☎ +46 18 471 4425 ➔ Per-Ola.Carlsson@mcb.uu.se Olle Korsgren, MD, PhD ☎ +46 18 6114187 ➔ Olle.Korsgren@klinimm.uu.se |
PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)
| Status: | Active, not recruiting |
| First Received: | June 2, 2008 |
| Information provided by: | Osiris Therapeutics |
| Sponsors and Collaborators: | Osiris Therapeutics |
| Contacts: | / |
Autologous Mesenchymal Stem Cell and Bone Marrow Stem Cell Infusion Combined With Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus
| Status: | Recruiting |
| First Received: | October 6, 2008 |
| Information provided by: | Fuzhou General Hospital |
| Sponsors and Collaborators: | Fuzhou General Hospital |
| Contacts: | Jianming Tan, Professor ☎ 008613375918000 ➔ doctortjm@yahoo.com |
Stem Cell Therapy for Type 2 Diabetes Mellitus
| Status: | Not yet recruiting |
| First Received: | June 10, 2010 |
| Information provided by: | Cellonis Biotechnology Co. Ltd. |
| Sponsors and Collaborators: | Cellonis Biotechnology Co. Ltd. |
| Contacts: | / |
Stem Cell Therapy for Type 1 Diabetes Mellitus
| Status: | Not yet recruiting |
| First Received: | June 10, 2010 |
| Information provided by: | Cellonis Biotechnology Co. Ltd. |
| Sponsors and Collaborators: | Cellonis Biotechnology Co. Ltd. |
| Contacts: | / |
Intraarterial Infusion of Autologous Mesenchymal Stem Cells From Adipose Tissue in Diabetic Patients With Chronic Critical Limb Ischemia (CeTMAd/ICPD200)
| Status: | Recruiting |
| First Received: | June 10, 2010 |
| Information provided by: | Fundacion Progreso y Salud, Spain |
| Sponsors and Collaborators: | Fundacion Progreso y Salud, Spain |
| Contacts: | Carlos III Health Institute Ana Cardesa |
Intraarterial Infusion of Autologous Mesenchymal Stem Cells From Adipose Tissue in Diabetic Patients With Chronic Critical Limb Ischemia (CeTMAd/ICPD200)
| Status: | Recruiting |
| First Received: | June 10, 2010 |
| Information provided by: | Fundacion Progreso y Salud, Spain |
| Sponsors and Collaborators: | Fundacion Progreso y Salud, Spain |
| Contacts: | Carlos III Health Institute Ana Cardesa ☎ 0034 955 01 9040 |
Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia in Diabetic Patients
| Status: | Recruiting dacion |
| First Received: | March 25, 2008 |
| Information provided by: | Fundacion Progreso y Salud, Spain |
| Sponsors and Collaborators: | Progreso y Salud, Spain |
| Contacts: | Carlos III Health Institute Inmaculada C Perez-Camacho, MD, PhD ☎ +34955693440 ➔ Ipercam06@gmail.com Rafael J Ruiz-Salmerón, MD, PhD ☎ +34955693440 ➔ rjruizsalmeron@yahoo.es |
Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients
| Status: | Recruiting |
| First Received: | March 25, 2008 |
| Information provided by: | Fuzhou General Hospital |
| Sponsors and Collaborators: | Fuzhou General Hospital |
| Contacts: | Jianming Tan, Professor ☎ 008613375918000 ➔ tanjm156@yahoo.com.cn |
Induced Wound Healing by Application of Expanded Bone Marrow Stem Cells in Diabetic Patients With Critical Limb Ischemia
| Status: | Completed |
| First Received: | February 8, 2010 |
| Information provided by: | Ruhr University of Bochum |
| Sponsors and Collaborators: | Ruhr University of Bochum |
| Contacts: | / |
Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot
| Status: | Not yet recruiting |
| First Received: | October 6, 2010 |
| Information provided by: | Qingdao University |
| Sponsors and Collaborators: | Qingdao University |
| Contacts: | Jianxia Hu, MD ☎ 86-0532-82911676 ➔ qdyxyhjx@126.com Hong Gao, MS ☎ 86-0532-82911676 ➔ honggaogloria@gmail.com |
Comparison of Autologous Mesenchymal Stem Cells and Mononuclear Cells on Diabetic Critical Limb Ischemia and Foot Ulcer
| Status: | Completed |
| First Received: | August 4, 2009 |
| Information provided by: | Third Military Medical University |
| Sponsors and Collaborators: | Third Military Medical University |
| Contacts: | / |
The Role of Lipoaspirate Injection in the Treatment of Diabetic Lower Extremity Wounds and Venous Stasis Ulcers
| Status: | Not yet recruiting |
| First Received: | December 24, 2008 |
| Information provided by: | Washington D.C. Veterans Affairs Medical Center |
| Sponsors and Collaborators: | Washington D.C. Veterans Affairs Medical Center |
| Contacts: | / |
Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus
| Status: | This study is ongoing, but not recruiting participants. |
| First Received: | June 15, 2011 |
| Information provided by: | Fuzhou General Hospital |
| Sponsors and Collaborators: | Fuzhou General Hospital |
| Contacts: | / |
Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients
| Status: | This study is not yet open for participant recruitment. |
| First Received: | December 18, 2011 |
| Information provided by: | S-Evans Biosciences Co.,Ltd. |
| Sponsors and Collaborators: |
|
| Contacts: | Charlie Xiang, Professor 86-571-87236436 cxiang@zju.edu.cn |
